Inviragen Acquisition By Takeda Worth Up To $250M

The acquisition of Fort Collins, Colorado-based Inviragen could be worth up to $250M for the company's backers, based on its milestones. Takeda Pharmaceutical and Inviragen announced the acquisition deal Tuesday, saying that Takeda will pay...
READ MORE...


























































